Logo

Japan's NCRI Uses Nonlinear Dynamics' Proteomics Software in Biomarker Hunt

Oct 04, 2007
NEW YORK (GenomeWeb News) - Japan's National Cancer Research Institute is using Nonlinear Dynamics' 2D gel analysis software in research aimed at discovering and validating biomarkers for cancer diagnostics, the company said today.
 
The NCRI is using the company’s Progenesis SameSpots image analysis platform to develop biomarker candidates that would predict response to the cancer therapy gefitinib in lung adenocarcinoma. The project is also planning to identify markers that will predict a patient's risk of cancer recurrence, the company said.
 
The NCRI’s clinical proteomics group currently runs more than 1,500 2D-DIGE gels per year.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.